Risk of gastric cancer dependent on serological markers atrophic gastritis: Cohort study

Voprosy Onkologii

Volumn 58, Issue 5, 2012, Pages 644-648

  Reshetnikov, O V ^a   Openko, T G ^a   Simonova, G I ^a   Kurilovich, S A ^a   Malyutina, S K ^a   Ragino, Yu I ^a   Voevoda, M I ^a  

^a Institute of Therapy   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; GASTRIN 17; HELICOBACTER PYLORI ANTIBODY; PEPSINOGEN I; PEPSINOGEN II; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; COHORT ANALYSIS; GROUPS BY AGE; HUMAN; SEROLOGY; STOMACH CANCER;

AGED; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; PEPSINOGENS; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; STOMACH NEOPLASMS;

EID: 84875553882     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cancer Registration: Principles and Methods. Edited by O.M.Jensen, D.M.Parkin, R.MacLennan, C.S.Muir, R.G.Skeet // International Agency for Research of Cancer. - Lyon, France, 1991. - P. 288.
2. Crew K.D., Neugut A.I. Epidemiology of gastric cancer // World. J. Gastroenterol. - 2006. - Vol. 12. - P. 354-362.
3. Iijima K., Abe Y., Kikuchi R. et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach // World. J. Gastroenterol. - 2009. - Vol.15. - P. 853-859.
4. Kokkola A., Kosunen T.U., Puolakkainen P. et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis // APMIS. - 2003. - Vol. 111. - P. 619-624.
5. Kosunen T.U., Pukkala E. et al. Gastric cancers in finnish patients after cure of helicobacter pylori infection: a cohort study // Int.J. Cancer. - 2011. - Vol.128. - P. 433-439.
6. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification // Acta Pathol. Microbiol. Scand. - 1965. - Vol. 64. - P. 31-49.
7. Leja M., Kupcinskas L., Funka K. et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology // Dig Dis Sci. - 2009. - Vol. 54. - P. 2377-2384.
8. Miki K., Fujishiro M. Cautious comparison between East and West is necessary in terms of the serum pepsinogen test // Dig Endoscop. - 2009. - Vol.21. - P. 134-135.
9. Mizuno S., Miki I., Ishida T. et al. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis // Dig Dis Sci. - 2010. - Vol. 55. - P. 3132-3137.
10. Sipponen P., Kekki M., Haapakoski J. et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data // Int. J. Cancer. - 1985. - Vol. 35. - P. 173-177.
11. Watabe H., Mitsushima T., Yamaji Y. et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study // Gut. - 2005. - Vol. 54. - P. 764-768.
12. Yamaji Y., Watabe H., Yoshida H. et al. High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors // Helicobacter. - 2009. - Vol. 14. - P. 81-86.
13. Yanaoka K., Oka M., Yoshimura N. et al. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels // Int. J. Cancer. - 2008. - Vol. 123. - P. 917-926.
14. http://www.biohit.com